Financhill
Back

Realty Income Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
51

O
Realty Income

Last Price:
62.72
Seasonality Move:
2.17%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
54.41
Seasonality Move:
7.55%
Buy
51
Realty Income (O) is a Buy

Is Realty Income a Buy, Sell or Hold?

  • The current Realty Income [O] share price is $62.73. The Score for O is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • O is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

O Stock Price Chart

What is Realty Income's stock price today?

  • The Realty Income share price today is $62.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and O is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $54.43
    The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

O Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.5 Buy
Relative Strength Index (14 RSI): 59.44 Buy
Chaikin Money Flow: -2050715 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.7 - 62.78) Buy
Bollinger Bands (100): (53.42 - 61.1) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 43.18 Sell
Chaikin Money Flow: -435004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.76 - 58.26) Sell
Bollinger Bands (100): (40.14 - 54.08) Buy

O Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.16 Buy
20-day SMA: 62.38 Buy
50-day SMA: 60.74 Buy
200-day SMA: 55.77 Buy
8-day EMA: 62.41 Buy
20-day EMA: 62.1 Buy
50-day EMA: 60.51 Buy
200-day EMA: 57.05 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.08 Sell
20-day SMA: 56.96 Sell
50-day SMA: 52.99 Buy
200-day SMA: 46.88 Buy
8-day EMA: 56.5 Sell
20-day EMA: 56.46 Sell
50-day EMA: 53.4 Buy
200-day EMA: 47.32 Buy

Realty Income Earnings Growth & O Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.08 per share, an increase this year of $0.03 per share, and an increase next year of $0.29 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.

Realty Income Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):